Company Data
Brainstorm Cell Therapeutics Inc.
Ticker
BCLI
Current Price
$0.4947 31.05%
Market Cap
$33.8M
Price Target
Refer to Report
Volume
979.6K
52wk Range
$0.134 - $3.34
Overview
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is a developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS), and Parkinson’s disease (PD). Brainstorm’s NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.